product summary
Loading...
company name :
R&D Systems
product type :
antibody
product name :
TRAIL/TNFSF10 Antibody (B-S23) [DyLight 488]
catalog :
NBP3-14602G
quantity :
0.1 ml
price :
399 USD
clonality :
monoclonal
host :
mouse
conjugate :
DyLight488
clone name :
B-S23
reactivity :
human
application :
ELISA, flow cytometry
more info or order :
product information
brand :
Novus
master code :
NBP3-14602G
SKU :
NBP3-14602G
product name :
TRAIL/TNFSF10 Antibody (B-S23) [DyLight 488]
sizes available :
0.1 ml
description :
The TRAIL/TNFSF10 Antibody (B-S23) [DyLight 488] from NBP3-14602G is a 5.7e-05 antibody to . This antibody reacts with human.
target :
TRAIL/TNFSF10
category :
Primary Antibodies
buffer :
50mM Sodium Borate
clonality :
Monoclonal
clone :
B-S23
conjugate :
DyLight 488
all_available conjugate :
Alexa Fluor 488;DyLight 488
dilution :
Flow Cytometry, ELISA
host :
Mouse
immunogen :
Recombinant human TRAIL/TNFSF10
isotype :
IgG1 Kappa
purity :
Affinity purified
species :
Human
gene symbol :
TNFSF10
applications :
Flow Cytometry,ELISA
USD :
399 USD
alt names :
Apo-2 ligand, APO2L, Apo-2Ltumor necrosis factor (ligand) family, member 10, APO2Ltumor necrosis factor apoptosis-inducing ligand splice variant delta, CD253, CD253 antigen, Protein TRAIL, TL2, TNF-related apoptosis-inducing ligand, TRAILTNF-related apoptosis inducing ligand TRAIL, tumor necrosis factor (ligand) superfamily, member 10, tumor necrosis factor ligand superfamily member 10
storage :
Store at 4C in the dark.
more info or order :
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
related products
browse more products
questions and comments
